• Lorenz von Seidlein, Mohammad Jiddawi, Rebecca F Grais, Francisco Luquero, Marcelino Lucas, and Jacqueline Deen.
• Menzies School of Health Research, Casuarina, Australia.
• J. Infect. Dis. 2013 Nov 1; 208 Suppl 1: S8-14.

AbstractThe 21st century saw a shift in the cholera burden from Asia to Africa. The risk factors for cholera outbreaks in Africa are incompletely understood, and the traditional emphasis on providing safe drinking water and improving sanitation and hygiene has proven remarkably insufficient to contain outbreaks. Current killed whole-cell oral cholera vaccines (OCVs) are safe and guarantee a high level of protection for several years. OCVs have been licensed for >20 years, but their potential for preventing and control cholera outbreaks in Africa has not been realized. Although each item in the long list of technical reasons why cholera vaccination campaigns have been deferred is plausible, we believe that the biggest barrier is that populations affected by cholera outbreaks are underprivileged and lack a strong political voice. The evaluation and use of OCVs as a tool for cholera control will require a new, more compassionate, less risk-averse generation of decision makers.

26 keywords...

hide…